1. Home
  2. PAGS vs EWTX Comparison

PAGS vs EWTX Comparison

Compare PAGS & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PAGS

PagSeguro Digital Ltd.

HOLD

Current Price

$10.05

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$26.92

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAGS
EWTX
Founded
2006
2017
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PAGS
EWTX
Price
$10.05
$26.92
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$11.71
$34.13
AVG Volume (30 Days)
3.0M
1.7M
Earning Date
02-19-2026
03-02-2026
Dividend Yield
1.39%
N/A
EPS Growth
16.68
N/A
EPS
1.37
N/A
Revenue
$3,662,823,389.00
N/A
Revenue This Year
$14.61
N/A
Revenue Next Year
$5.39
N/A
P/E Ratio
$7.37
N/A
Revenue Growth
10.88
N/A
52 Week Low
$6.50
$10.60
52 Week High
$11.16
$30.48

Technical Indicators

Market Signals
Indicator
PAGS
EWTX
Relative Strength Index (RSI) 51.86 59.20
Support Level $9.84 $23.57
Resistance Level $10.45 $28.29
Average True Range (ATR) 0.36 1.47
MACD 0.03 0.22
Stochastic Oscillator 59.13 79.84

Price Performance

Historical Comparison
PAGS
EWTX

About PAGS PagSeguro Digital Ltd.

PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

Share on Social Networks: